Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03836235 · ClinicalTrials.gov registry record

Development of a Risk Prediction Screening Tool for Opioid-Prescription Injury (STOP Injury) in Older Adults Initiated on Opioids From the Emergency Department

A clinical trial, sponsored by University of Florida.

Completed
Registry status
44
Enrollment target

NCT03836235: Completed study, sponsored by University of Florida.

NCT03836235 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 44 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03836235 has completed, sponsored by University of Florida.

COMPLETED
Registry status
44 participants
Enrollment target

Study Summary

The long-term goal of this project is to promote responsible opioid prescribing, immediately improving patient safety and ultimately decreasing healthcare costs by reducing older adult morbidity and mortality due to opioid-related injury. The objective of this pilot project is to gather data to inform the development of the STOP Injury tool and evaluate additional predictive factors and important outcomes relevant to prescription opioids.

Primary Outcome

The study team will analyze the association between candidate risk factors and opioid adverse events (falls and OD).

Trial Details

FieldValue
Enrollment Target 44 participants
Start Date 2019-03-04
Est. Completion 2020-04-03
University of Florida

1,106 total trials

What the finished NCT03836235 record still lists

NCT03836235 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 44 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT03836235 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03836235 about?

NCT03836235 is a clinical study titled "Development of a Risk Prediction Screening Tool for Opioid-Prescription Injury (STOP Injury) in Older Adults Initiated on Opioids From the Emergency Department". The long-term goal of this project is to promote responsible opioid prescribing, immediately improving patient safety and ultimately decreasing healthcare costs by reducing older adult morbidity and mortality due to opioid-related injury. The objective of this pilot project is to gather data to info...

What is the current status of trial NCT03836235?

This trial is currently completed. The enrollment target is 44 participants. The study started on 2019-03-04. Estimated completion is 2020-04-03.

Who is sponsoring clinical trial NCT03836235?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02323945 · 44 participants · NA

    Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury

  • NCT03093909 · 44 participants · Phase 1

    Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases

  • NCT03104491 · 44 participants · Phase 1

    Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia

  • NCT03781765 · 44 participants · Phase 4

    Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03836235, the US trial registry maintained by the National Library of Medicine. NCT03836235 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.